Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
暂无分享,去创建一个
E. Scarpi | D. Amadori | D. Calistri | M. Canale | P. Ulivi | G. Marisi | G. Frassineti | A. Passardi | M. Valgiusti